MedTrace Logo

2L Oral Bi-PegLyte Versus 2L Oral MoviPrep Regimen for Outpatient Colonic Preparation

NCT01865916 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 309

Last updated 2016-06-20

No results posted yet for this study

Summary

This study is a randomized, controlled, single centre, endoscopist-blinded non-inferiority trial. The purpose of our study is to determine if using a 2-litre mixture in combination with vitamin C is better than using 2 litres of mixture with bisacodyl tablets. Two-litre PegLyte based preparations with an added laxative agent are commonly used for colonoscopies in outpatient settings. If the investigators discover that a 2-litre mixture with either the tablets or the ascorbic acid work better, future patients undergoing colonoscopy will be able to experience fewer side effects and be less troubled by the preparation while still allowing a good view of the colon.

Conditions

  • Colonoscopy

Interventions

DRUG

Polyethylene Glycol (PEG) and 15 mg Bisacodyl

Subjects will be asked to take split dose of 2L PEG and 3 tablets of 5 mg Bisacodyl

DRUG

Polyethylene Glycol (PEG) + ascorbic acid

Subjects will be asked to take split dose of 2L PEG and vitamin C

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Robert Enns, MD, FRCP · University of British Columbia

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-12-31
Completion
2016-02-29

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01865916 on ClinicalTrials.gov